- Home
- NRXP vs DXR Comparison
NRXP vs DXR Comparison
Compare NRXP & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- DXR
- Stock Information
- Founded
- NRXP 2015
- DXR 1970
- Country
- NRXP United States
- DXR United States
- Employees
- NRXP N/A
- DXR N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- DXR Medical/Dental Instruments
- Sector
- NRXP Health Care
- DXR Health Care
- Exchange
- NRXP Nasdaq
- DXR Nasdaq
- Market Cap
- NRXP 32.6M
- DXR 36.4M
- IPO Year
- NRXP N/A
- DXR N/A
- Fundamental
- Price
- NRXP $3.50
- DXR $9.63
- Analyst Decision
- NRXP Strong Buy
- DXR Strong Buy
- Analyst Count
- NRXP 4
- DXR 1
- Target Price
- NRXP $28.50
- DXR $25.00
- AVG Volume (30 Days)
- NRXP 295.0K
- DXR 5.1K
- Earning Date
- NRXP 08-13-2025
- DXR 01-01-0001
- Dividend Yield
- NRXP N/A
- DXR N/A
- EPS Growth
- NRXP N/A
- DXR 86.16
- EPS
- NRXP N/A
- DXR 0.11
- Revenue
- NRXP N/A
- DXR $119,714.00
- Revenue This Year
- NRXP N/A
- DXR N/A
- Revenue Next Year
- NRXP N/A
- DXR N/A
- P/E Ratio
- NRXP N/A
- DXR $86.39
- Revenue Growth
- NRXP N/A
- DXR N/A
- 52 Week Low
- NRXP $1.10
- DXR $6.55
- 52 Week High
- NRXP $6.01
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- NRXP 66.15
- DXR 69.88
- Support Level
- NRXP $2.90
- DXR $8.68
- Resistance Level
- NRXP $3.61
- DXR $9.03
- Average True Range (ATR)
- NRXP 0.28
- DXR 0.47
- MACD
- NRXP -0.03
- DXR 0.03
- Stochastic Oscillator
- NRXP 64.59
- DXR 90.38
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.